ED attaches Rs 2.58 crore property of HP Assistant Drug Controller

Shimla:  The Enforcement Directorate has provisionally attached two immovable properties worth Rs 2.58 crore as part of a money laundering probe against Assistant Drug Controller in Himachal Pradesh, Nishant Sareen, and his associate Komal Khanna, the agency said in a statement on Wednesday.

The assets, which were attached on December 2, include a residential building in Shimla and an apartment in Sector 20 of Haryana’s Panchkula.

The ED has been carrying out the investigation based on an FIR registered by the Himachal Pradesh State Vigilance and Anti-Corruption Bureau under Section 11 of the Prevention of Corruption Act, 1988.

The FIR accused Sareen of bribery, forgery and corruption when he was posted as Assistant Drug Controller at Baddi in Solan district.

Sareen was subsequently arrested, and a chargesheet was filed in 2021 against him and Khanna.

In 2022, Haryana Police registered another FIR against Sareen, Khanna and their other associates for alleged extortion, intimidation and forgery of the partnership deed of Zhenia Pharmaceuticals located in Panchkula.

Investigation revealed that Sareen’s official position was misused to allegedly raise Khanna’s share in the firm from 50 per cent to 95 per cent.

On September 23, 2025, a third FIR was registered against Sareen, accusing him of accumulating disproportionate assets worth Rs 1.66 crore while he was posted as Drug Inspector and Assistant Drug Controller in Himachal Pradesh.

The ED stated that Sareen, while being posted in various locations including Nahan, Baddi and Solan, had misused his position to collect illegal compensation from pharmaceutical manufacturers and distributors.

The probe also revealed that several pharmaceutical companies were coerced into conducting business at heavy losses with Zhenia Pharmaceuticals and Nia Pharma, both allegedly controlled and managed by Khanna.

The proceeds of crime were allegedly channelled into acquisition of personal assets, bank deposits, and properties held in the names of Khanna and Sareen’s family members.

 

Related Posts

Over 9,000 deaths due to respiratory diseases in Delhi

New Delhi:  The national capital recorded 9,211 deaths due to respiratory diseases in 2024, up from 8,801 in 2023, continuing an upward trend seen over the past few years, according…

Nebuliser, inhaler demand for children jumps by up to 60 pc in Delhi winters: Survey

New Delhi:  The demand for nebulisers, inhalers and respiratory medicines for children has surged sharply in Delhi during winter months, with chemists reporting spikes of up to 60 per cent…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Over 9,000 deaths due to respiratory diseases in Delhi

Over 9,000 deaths due to respiratory diseases in Delhi

Nebuliser, inhaler demand for children jumps by up to 60 pc in Delhi winters: Survey

Nebuliser, inhaler demand for children jumps by up to 60 pc in Delhi winters: Survey

Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

Ayurveda practitioner fined by ISM Council for violation of professional ethics

Ayurveda practitioner fined by ISM Council for violation of professional ethics

Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab